AE Wealth Management »

Vaneck Vectors Pharmaceutical etf shares owned by AE Wealth Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by AE Wealth Management from 13F filings

Historical chart of AE Wealth Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by AE Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by AE Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $91k 1.0k 90.39
2025-06-30 $88k 1.0k 87.96
2025-03-31 $95k 1.0k 91.10
2024-12-31 $41k 479 86.22
2022-09-30 $221k 3.3k 67.34
2022-06-30 $268k 3.5k 76.79

More positions owned by AE Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
American Centy Etf Tr Avantis Core Fi (AVIG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadcom (AVGO)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Rus Tp200 Gr Etf (IWY)
JPMorgan Chase & Co. (JPM)

View all positions for AE Wealth Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf